Loading clinical trials...
Loading clinical trials...
Effect of Acarbose and Fixed Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes Receiving Anti-diabetic Monotherapy
Conditions
Interventions
Metformin plus pioglitazone
Acarbose
Locations
1
China
Nanjing First Hospital, Nanjing Medical Univesity
Nanjing, China
Start Date
April 10, 2022
Primary Completion Date
May 31, 2023
Completion Date
May 31, 2023
Last Updated
November 29, 2022
NCT07051005
NCT07296484
NCT06671587
NCT06688461
NCT07053319
NCT06579404
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions